- Home
- AMST vs NCNA Comparison
AMST vs NCNA Comparison
Compare AMST & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMST | NCNA |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | 12 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 9.7M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AMST | NCNA |
|---|---|---|
| Price | $1.41 | $2.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.3M | 36.7K |
| Earning Date | 05-13-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $110,459.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.77 | $0.03 |
| 52 Week High | $4.78 | $10.00 |
Technical Indicators
Market Signals| Indicator | AMST | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 59.61 |
| Support Level | $0.83 | $1.97 |
| Resistance Level | $2.07 | $2.28 |
| Average True Range (ATR) | 0.31 | 0.18 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 34.21 | 80.36 |
Price Performance
Historical ComparisonAbout AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.